Healthcare


Terumo BCT Launches First-of-its-Kind Device to Accelerate Cell Therapy Manufacturing

Terumo BCT launches First-of-its-Kind device to accelerate cell therapy manufacturing. 
(Photo: Terumo BCT, PR001)Terumo BCT’s latest cell therapy technology, the Finia Fill and Finish System, is a first-of-its-kind device developed to help bring reproducibility and control to cell therapy manufacturing to get therapies to more patients who need them.

科莱恩MEVOPUR®添加剂技术助力医疗器械的激光焊接

Clariant作为全球领先的色母粒和改性料制造商,科莱恩塑料和涂料业务正在参加于9月25日至27日在上海举行的医学设计与制造贸易展览会——2019 Medtec中国展,展示由其新型MEVOPUR聚合物材料制成的医疗器械和部件,这些新型聚合物材料可提高激光焊接的性能。

科莱恩控制降低导管中显影聚合物的水解降解风险

Clariant作为全球领先的色母粒和改性料制造商,科莱恩塑料与涂料业务正在推出一种全新的聚合物改性料,可专门控制降低甚至是消除水解降解,抑制水解对导管常用材料的影响。该创新树脂产品以MEVOPUR品牌命名,将于9月25日至27日在上海举行的Medtec中国展上亮相。

Terumo BCT Offers $100,000 Research Grant Supporting Patient Access to Care

Terumo BCT offers $100,000 research grant supporting patient access to care
(Photo: Terumo BCT, PR002) Terumo BCT’s new USD $100,000 Therapeutic Plasma Exchange (TPE) Innovation Award will help clinical investigators expand the field of data for certain types of autoimmune conditions, known as IgG4-mediated diseases.

科莱恩MEVOPUR®医疗改性料工厂通过ISO 13485新标准认证

Clariant作为全球领先的色母粒和改性料制造商,科莱恩塑料与涂料业务近日宣布,其位于美国缅因州路易斯顿、瑞典马尔默和新加坡的工厂均已通过了针对塑料医疗器械制造商的严格的全新质量标准认证。这些工厂专门生产MEVOPUR品牌的医用聚合物改性料和色母粒。

Avery Dennison names Robyn Buma vice president of global procurement

Avery Dennison names Robyn Buma vice president of global procurement.
(Photo: Avery Dennison, PR433)Avery Dennison announces the promotion of Robyn Buma to vice president of global procurement for the company’s Label and Graphic Materials and Industrial and Healthcare Materials segments.

More